Patent ID: 8895538

Claim:
A pharmaceutical composition for topical application, useful in the treatment of localized dermatosis ailments accompanied with inflammation, concomitantly with infections caused by bacterial and mycotic organisms, comprising, per each 100 mg of composition: from 0.5 to 8.0 mg of fusidic acid; from 0.25 to 5.0 mg of clotrimazole; from 0.01 to 2.0 mg of betamethasone salt; from 5.0 to 6.5 mg of a first dispersing agent; from 3.2 to 4.5 mg of an emulsifying agent; from 0.3 to 0.5 mg of a second dispersing agent; from 2.5 to 3.5 mg of a moisturizing agent; and from 74.0 to 84.0 mg of water.